Articles By Eric Larson
-
USP <788> Revisions And Why Packaging Matters More Than Ever
5/12/2026
Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.
-
Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality
5/12/2026
Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.
-
Ethylene Oxide At A Crossroads
5/12/2026
Ensure your medical devices meet regulatory requirements and avoid costly release delays with comprehensive Ethylene Oxide Residuals Testing supported by expert guidance on ISO 10993-7 compliance.
-
Discover Medbio's Advanced Manufacturing Expertise for Robot-Assisted Surgery At DeviceTalks Boston 2026
5/12/2026
Visit Medbio at DeviceTalks Boston 2026 to explore scalable manufacturing solutions supporting next-generation robot-assisted surgical systems, precision molding, automation, assembly, and commercialization.
-
05.12.26 -- West Vantage: End-to-End Combination Product Solutions
5/12/2026
05/12/26 Med Device Online Newsletter
-
Accuracy, Safety And Ease Of Use
5/12/2026
Safety, ease of use, and accuracy guide modern medical device design, advancing through improved materials, engineering innovation, standards adoption, and user‑centered development.
-
05.12.26 -- Advancing Quality And Risk Management In MedTech
5/12/2026
05/12/26 Med Device Online Newsletter
-
Effective Strategies To Minimize Product Loss During Fill Finish
5/11/2026
Every drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.
-
Updates For Breathing Gas Pathways
5/11/2026
ISO 18562:2024 introduces significant changes that are reshaping testing strategies, risk assessments, and regulatory compliance expectations for medical devices.
-
Cryostorage Bag CCI Challenges Solution
5/11/2026
As regulatory expectations from the USP and FDA continue to evolve, deterministic testing methods are increasingly preferred for their reproducibility, reliability, and reduced sample requirements.